Intel stock hit new all-time highs for the first time since 2000, surging 85% in 18 months on AI chip demand and its 18A ...
Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...
Against what could already be considered a conservative consensus, especially for revenues, for the last three consecutive ...
Why Businesses Hesitate Even When They - Latest Business news, analysis, and insights from Global Banking & Finance Review.
In 2026, tech leaders are learning a painful lesson: the problem with scaling AI adoption isn't understanding the algorithm, ...
A new study analyzing vehicle recalls shows that in the past 12 months, Ford Motor Co. recalled 19.6 million vehicles, more ...
Women with high genetic risk for obesity regained weight around two times faster than women with lower genetic risk for obesity, according to a new study led by Harold Lee, assistant professor of ...
As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...
A widely used diabetes drug has come under new scrutiny after two large studies found it may be linked to a rare but serious ...
The data center industry is having a power problem. The problem is at the rack. Artificial intelligence (AI) is driving rack ...
A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results